Your Name (required)
Your Email (required)
We strive to develop innovative products for the safe, effective treatment of rare diseases and unmet needs for our number one priority- Our patients.
Our technology platform includes a unique, GMP compliant,
validated process that has proven capable of producing industrial quantities
of pure recombinant human proteins.
We have established partnerships for the most important markets,
the United States of America, and Europe, and also have our own
commercialisation activities in the Netherlands, Austria and Germany.
The next General Meeting of Shareholders will be held on 24 May, 2017 at 14:00 PM (CET) at Holiday Inn Leiden, Haagse [...]
Click to download the Pharming Annual Report 2016
17may07:00- 09:001st Quarterly Results
(Wednesday) 07:00 - 09:00
24may14:00- 17:00Annual General Meeting 2017
(Wednesday) 14:00 - 17:00
Haagse Schouwweg 10, 2332 KG Leiden, the Netherlands
Pharming Group NV
27jul07:00- 09:001H Results
(Thursday) 07:00 - 09:00